For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

Newcastle University

Return to search Previous output Next output
Output 0 of 0 in the submission
Article title

Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-α treatment

Type
D - Journal article
Title of journal
Blood
Article number
-
Volume number
111
Issue number
3
First page of article
1039
ISSN of journal
1528-0020
Year of publication
2008
Number of additional authors
16
Additional information

The author made a substantial contribution to the conception and design of the study, to the organisation of the conduct of the study, to carrying out the study (including acquisition of study data), to analysis and interpretation of study data, AND the author helped draft the output.

Interdisciplinary
-
Cross-referral requested
-
Research group
B - Cancer
Citation count
136
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-